Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10181353 | PMC |
| http://dx.doi.org/10.14740/jocmr4914 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Development and Validation of a Scaffold-Free Human Multilineage Spheroid Model for Early Stage Cholangiopathies Driven by Cholangiocyte Senescence.
Liver Int
October 2025
GastroZentrum Hirslanden, Digestive Disease Center, Zürich, Switzerland.
Background And Aims: Cholangiopathies, including primary sclerosing cholangitis (PSC), primary biliary cholangitis (PBC), and post-COVID-19 cholangiopathy (PCC), involve chronic cholangiocyte injury, senescence, epithelial-stromal crosstalk, and progressive fibrosis. However, effective in vitro models to capture these interactions are limited. Here, we present a scaffold-free 3D multilineage spheroid model, composed of hepatocyte-like cells (HepG2), cholangiocytes (H69), and hepatic stellate cells (LX-2), designed to recapitulate early fibrogenic responses driven by senescent cholangiocytes.
View Article and Find Full Text PDFDuct and cover: a case of post-COVID-19 cholangiopathy with large biliary cast removal.
Gastrointest Endosc
June 2025
Atrium Health Department of Gastroenterology and Hepatology, Charlotte, North Carolina, USA.
COVID-19-Related Cholangiopathy: Histological Findings.
Diagnostics (Basel)
August 2024
School of Medicine of Bahia, Federal University of Bahia, Salvador 40026-010, Brazil.
Unlabelled: Cholangiopathy has been described in survivors of severe COVID-19, presenting significant clinical parallels to the pre-pandemic condition of secondary sclerosing cholangitis in critically ill patients (SSC-CIP). We aimed to examine the liver histopathology of individuals with persistent cholestasis after severe COVID-19.
Methods: We subjected post-COVID-19 cholestasis liver samples to routine staining techniques and cytokeratin 7 immunostaining and semi-quantitatively analyzed the portal and parenchymal changes.
Post-COVID-19 Cholangiopathy: Clinical and Radiologic Findings.
Korean J Radiol
November 2023
Department of Radiology, Asan Medical Center, Seoul, Republic of Korea.
Endoscopic Features of Post-COVID-19 Cholangiopathy and Its Management Using ERCP.
Am J Gastroenterol
April 2024
Department of Hepatology and Gastroenterology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
Introduction: Despite growing awareness of post-coronavirus disease 2019 (COVID-19) cholangiopathy as one of the most serious long-term gastrointestinal consequences of COVID-19, the endoscopic features of this disease are still poorly characterized. This study aimed to more precisely define its endoscopic features and to outline the role of endoscopic retrograde cholangiopancreatography (ERCP) in the management of this entity.
Methods: In this observational study, 46 patients with confirmed post-COVID-19 cholangiopathy were included.